Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
Exact Sciences (EXAS) delivered earnings and revenue surprises of -8,300.00% and +2.07%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?